Physician

Steven Holt Stokes, M.D.

According to 2025 Medicare claims, Steven Stokes, M.D. (NPI: 1780752881) practices radiation oncology in the Panama City-Panama City Beach, FL market, with the plurality of this provider's patient population coming from Bay, FL. This provider's primary affiliated billing organization is OCALA ONCOLOGY CENTER PL (NPI: 1356300958; TIN: 900336929) and primary practice location at 32405-4587. Stokes is affiliated with the Primary Care Alliance, LLC (ACO ID: D0010), participating under the REACH model.

Stokes' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 202 traditional Medicare patients, billed 5,241 HCPCS/CPT codes, and received $827,492 in Medicare payments. The top billing code was 77427 (Radiation treatment management, 5 treatment sessions). Part D data shows 462 prescription claims across 129 beneficiaries totaling $15,524 in drug costs, led by Oxycodone Hcl (Oxycodone Hcl). 2023 DME data shows 12 claims. Open Payments data shows 87 records totaling $1,781. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $1,063,729 to $827,492. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $104,427 to $15,524. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $5,399 to $1,323.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,016	10,410	$1,063,729
2016	988	10,367	$1,075,405
2017	829	10,505	$1,246,807
2018	523	8,956	$1,264,944
2019	227	6,833	$879,046
2020	184	4,765	$679,991
2021	161	3,501	$573,301
2022	173	3,856	$624,251
2023	199	4,526	$691,940
2024	202	5,241	$827,492

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	398	2,632	$104,427
2016	387	2,685	$124,673
2017	398	2,651	$89,801
2018	296	2,144	$64,354
2019	183	1,126	$41,044
2020	130	647	$21,955
2021	81	225	$4,638
2022	80	218	$6,670
2023	91	307	$8,028
2024	129	462	$15,524

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	49	168	$18,510
2016	68	157	$19,472
2017	17	81	$4,683
2018	11	31	$1,724
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	12	$2,498
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
77427	Radiation treatment management, 5 treatment sessions	107	370	$150
77334	Design and construction of complex radiation treatment device	92	189	$96
77014	Ct guidance for insertion of radiation therapy fields	95	1,168	$91
77336	Continuing radiation therapy consultation per week	107	354	$68
77300	Calculation of radiation therapy dose	96	395	$50

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycodone Hcl	Oxycodone Hcl	90	2,237	$2,561
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	30	760	$955
Morphine Sulfate Er	Morphine Sulfate	35	1,050	$839
Ondansetron Hcl	Ondansetron Hcl	17	270	$633
Ssd	Silver Sulfadiazine	23	624	$351

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	87	$1,781	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Steven Holt Stokes, M.D.?

Tedicare shows public-source Medicare data for Steven Holt Stokes, M.D. (NPI 1780752881), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Steven Holt Stokes, M.D. have ACO affiliation data?

Steven Holt Stokes, M.D. is shown with ACO affiliation data for Primary Care Alliance, LLC (REACH, ACO ID D0010).

What billing organization is linked to Steven Holt Stokes, M.D.?

Steven Holt Stokes, M.D. is linked to OCALA ONCOLOGY CENTER PL (billing NPI 1356300958) in the available physician profile data.

Does Steven Holt Stokes, M.D. have Open Payments data?

Steven Holt Stokes, M.D. has 87 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.